Please use this identifier to cite or link to this item: 10.3390/ijms24065528
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZelencova-Gopejenko, Diana-
dc.contributor.authorVideja, Melita-
dc.contributor.authorGrandane, Aiga-
dc.contributor.authorPudnika-Okinčica, Linda-
dc.contributor.authorSipola, Anda-
dc.contributor.authorVilks, Karlis-
dc.contributor.authorDambrova, Maija-
dc.contributor.authorJaudzems, Kristaps-
dc.contributor.authorLiepinsh, Edgars-
dc.date.accessioned2023-04-05T08:20:01Z-
dc.date.available2023-04-05T08:20:01Z-
dc.date.issued2023-03-14-
dc.identifier.citationZelencova-Gopejenko , D , Videja , M , Grandane , A , Pudnika-Okinčica , L , Sipola , A , Vilks , K , Dambrova , M , Jaudzems , K & Liepinsh , E 2023 , ' Heart-Type Fatty Acid Binding Protein Binds Long-Chain Acylcarnitines and Protects against Lipotoxicity ' , International Journal of Molecular Sciences , vol. 24 , no. 6 , 5528 . https://doi.org/10.3390/ijms24065528-
dc.identifier.issn1661-6596-
dc.identifier.otherPubMedCentral: PMC10058761-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/11283-
dc.descriptionFunding Information: This research was funded by the European Union’s Horizon 2020 research and innovation program project FAT4BRAIN under grant agreement No. 857394 and by Latvian Institute of Organic Synthesis internal student grants IG-2022-04 and IG-2023-04 (to D.Z.-G.). Publisher Copyright: © 2023 by the authors.-
dc.description.abstractHeart-type fatty-acid binding protein (FABP3) is an essential cytosolic lipid transport protein found in cardiomyocytes. FABP3 binds fatty acids (FAs) reversibly and with high affinity. Acylcarnitines (ACs) are an esterified form of FAs that play an important role in cellular energy metabolism. However, an increased concentration of ACs can exert detrimental effects on cardiac mitochondria and lead to severe cardiac damage. In the present study, we evaluated the ability of FABP3 to bind long-chain ACs (LCACs) and protect cells from their harmful effects. We characterized the novel binding mechanism between FABP3 and LCACs by a cytotoxicity assay, nuclear magnetic resonance, and isothermal titration calorimetry. Our data demonstrate that FABP3 is capable of binding both FAs and LCACs as well as decreasing the cytotoxicity of LCACs. Our findings reveal that LCACs and FAs compete for the binding site of FABP3. Thus, the protective mechanism of FABP3 is found to be concentration dependent.en
dc.format.extent4314455-
dc.language.isoeng-
dc.relation.ispartofInternational Journal of Molecular Sciences-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectFatty Acid Binding Protein 3/metabolism-
dc.subjectFatty Acid-Binding Proteins/metabolism-
dc.subjectFatty Acids pharmacology-
dc.subjectCarnitine-
dc.subjectMyocytes-
dc.subjectCardiac metabolism-
dc.subjectisothermal titration calorimetry-
dc.subjectlong-chain acylcarnitines-
dc.subject1.6 Biological sciences-
dc.subject3.1 Basic medicine-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.titleHeart-Type Fatty Acid Binding Protein Binds Long-Chain Acylcarnitines and Protects against Lipotoxicityen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article-
dc.identifier.doi10.3390/ijms24065528-
dc.contributor.institutionFaculty of Pharmacy-
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85151108933&partnerID=8YFLogxK-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.